<DOC>
	<DOCNO>NCT00186238</DOCNO>
	<brief_summary>To assess role autologous hematopoietic cell rescue treatment multiple myeloma .</brief_summary>
	<brief_title>High Dose Sequential Therapy Autologous Stem Cell Rescue Multiple Myeloma</brief_title>
	<detailed_description>To assess toxicity efficacy sequentially administer high dose cyclophosphamide VP-16 follow total body irradiation BCNU high dose mephalan autologous stem cell rescue treatment multiple myeloma .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>receive cytoreduction prior transplant adequate organ function previous transplant smolder MM benign monoclonal gammopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>